NCYT cornering the market28 Oct 2020 09:45
Anyone else read this point for today's ODX RNS as meaning NCYT has cornered the market? "ODX. Following initial orders for this test, traction has not materialised as the Company was originally anticipating. The Company believes this is due, in part, to competition from ELISA antibody tests that are now available on larger automated instruments and an evolving market need that seems more geared towards lateral flow antibody tests."